Abstract
Nef is a viral pathogenicity factor that has an important role in disease progression associated with HIV infection. Yet, no antiviral drugs capable of inhibiting of Nef are available or in clinical trials today. In this review the challenges and potential involved in pharmaceutical targeting of Nef are discussed in light of current understanding of the molecular mechanisms of Nef action, with a special emphasis on effector functions of Nef that are mediated via SH3 domain-directed interactions with host cell proteins.
Keywords: nef, hiv, aids, protein interactions, signal transduction, drug screening
Current Drug Targets - Immune, Endocrine & Metabolic Disorders
Title: Therapeutic Targeting of Interactions Between Nef and Host Cell Proteins
Volume: 4 Issue: 4
Author(s): Kalle Saksela
Affiliation:
Keywords: nef, hiv, aids, protein interactions, signal transduction, drug screening
Abstract: Nef is a viral pathogenicity factor that has an important role in disease progression associated with HIV infection. Yet, no antiviral drugs capable of inhibiting of Nef are available or in clinical trials today. In this review the challenges and potential involved in pharmaceutical targeting of Nef are discussed in light of current understanding of the molecular mechanisms of Nef action, with a special emphasis on effector functions of Nef that are mediated via SH3 domain-directed interactions with host cell proteins.
Export Options
About this article
Cite this article as:
Saksela Kalle, Therapeutic Targeting of Interactions Between Nef and Host Cell Proteins, Current Drug Targets - Immune, Endocrine & Metabolic Disorders 2004; 4 (4) . https://dx.doi.org/10.2174/1568005310404040315
DOI https://dx.doi.org/10.2174/1568005310404040315 |
Print ISSN 1568-0088 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-5917 |
Related Articles
-
Fulvestrant - A Novel Endocrine Therapy for Breast Cancer
Current Medicinal Chemistry Inhibitors of Aldo-Keto Reductases AKR1C1-AKR1C4
Current Medicinal Chemistry Immunotherapy of Kidney Cancer
Current Clinical Pharmacology The Epithelial-Stromal Interaction as a Potential Target for Breast Cancer Treatment
Clinical Cancer Drugs Toxicology of Tributyltin in Mammalian Animal Models
Immunology, Endocrine & Metabolic Agents in Medicinal Chemistry (Discontinued) Relaxin: New Functions for an Old Peptide
Current Protein & Peptide Science Platycodin D Induces Tumor Growth Arrest by Activating FOXO3a Expression in Prostate Cancer in vitro and in vivo
Current Cancer Drug Targets UV Sunscreens of Microbial Origin: Mycosporines and Mycosporine- like Aminoacids
Recent Patents on Biotechnology Novel Functions of MicroRNA-17-92 Cluster in the Endocrine System
Current Drug Targets Melatonin and Hypothalamic-Pituitary-Gonadal Axis
Current Medicinal Chemistry New Insights into the Molecular Mechanisms of Corticosteroids Actions
Current Drug Targets A Review of the Evidence for a Neuroendocrine Link Between Stress, Depression and Diabetes Mellitus
Current Diabetes Reviews A Novel Nanocarrier System for Cancer Treatment
Current Nanomedicine Management of Osteoporosis: Seeing the Future
Medicinal Chemistry Reviews - Online (Discontinued) An Insight into Drug Repositioning for the Development of Novel Anti-Cancer Drugs
Current Topics in Medicinal Chemistry Low Testosterone Levels and Metabolic Syndrome in Aging Male
Current Pharmaceutical Design Novel Hexahydropyridoindole Derivative as Prospective Agent Against Oxidative Damage in Pancreatic βCells
Medicinal Chemistry CYP3A4-mediated Pharmacokinetic Interactions in Cancer Therapy
Current Drug Metabolism Sunlight Vitamin D and Skin Cancer
Anti-Cancer Agents in Medicinal Chemistry Curcumin as an Adjuvant to Breast Cancer Treatment
Anti-Cancer Agents in Medicinal Chemistry